Intra-Cellular Therapies Statistics
Total Valuation
ITCI has a market cap or net worth of $14.02 billion. The enterprise value is $13.04 billion.
| Market Cap | 14.02B |
| Enterprise Value | 13.04B |
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ITCI has 106.33 million shares outstanding. The number of shares has increased by 7.56% in one year.
| Current Share Class | 106.33M |
| Shares Outstanding | 106.33M |
| Shares Change (YoY) | +7.56% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 84.84% |
| Float | 104.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 554.08 |
| PS Ratio | 19.97 |
| Forward PS | 14.60 |
| PB Ratio | 12.20 |
| P/TBV Ratio | 12.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.36, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.36 |
| Quick Ratio | 5.70 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.58% and return on invested capital (ROIC) is -8.23%.
| Return on Equity (ROE) | -8.58% |
| Return on Assets (ROA) | -6.96% |
| Return on Invested Capital (ROIC) | -8.23% |
| Return on Capital Employed (ROCE) | -10.05% |
| Revenue Per Employee | $791,688 |
| Profits Per Employee | -$86,833 |
| Employee Count | 860 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 15.45 |
Taxes
In the past 12 months, ITCI has paid $473,000 in taxes.
| Income Tax | 473,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.16% in the last 52 weeks. The beta is 0.46, so ITCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +93.16% |
| 50-Day Moving Average | 129.42 |
| 200-Day Moving Average | 92.67 |
| Relative Strength Index (RSI) | 84.55 |
| Average Volume (20 Days) | 2,330,625 |
Short Selling Information
The latest short interest is 2.67 million, so 2.51% of the outstanding shares have been sold short.
| Short Interest | 2.67M |
| Short Previous Month | 2.33M |
| Short % of Shares Out | 2.51% |
| Short % of Float | 2.55% |
| Short Ratio (days to cover) | 1.20 |
Income Statement
In the last 12 months, ITCI had revenue of $680.85 million and -$74.68 million in losses. Loss per share was -$0.72.
| Revenue | 680.85M |
| Gross Profit | 387.77M |
| Operating Income | -116.72M |
| Pretax Income | -83.40M |
| Net Income | -74.68M |
| EBITDA | -116.21M |
| EBIT | -116.72M |
| Loss Per Share | -$0.72 |
Balance Sheet
The company has $1.00 billion in cash and $16.98 million in debt, giving a net cash position of $984.09 million or $9.26 per share.
| Cash & Cash Equivalents | 1.00B |
| Total Debt | 16.98M |
| Net Cash | 984.09M |
| Net Cash Per Share | $9.26 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 10.81 |
| Working Capital | 1.10B |
Cash Flow
In the last 12 months, operating cash flow was -$73.18 million and capital expenditures -$322,000, giving a free cash flow of -$73.50 million.
| Operating Cash Flow | -73.18M |
| Capital Expenditures | -322,000 |
| Free Cash Flow | -73.50M |
| FCF Per Share | -$0.69 |
Margins
Gross margin is 56.95%, with operating and profit margins of -17.14% and -10.97%.
| Gross Margin | 56.95% |
| Operating Margin | -17.14% |
| Pretax Margin | -10.90% |
| Profit Margin | -10.97% |
| EBITDA Margin | -17.07% |
| EBIT Margin | -17.14% |
| FCF Margin | n/a |
Dividends & Yields
ITCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.56% |
| Shareholder Yield | -7.56% |
| Earnings Yield | -0.53% |
| FCF Yield | -0.52% |
Analyst Forecast
The average price target for ITCI is $106.75, which is -19.05% lower than the current price. The consensus rating is "Buy".
| Price Target | $106.75 |
| Price Target Difference | -19.05% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 37.82% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITCI has an Altman Z-Score of 20.41 and a Piotroski F-Score of 4.
| Altman Z-Score | 20.41 |
| Piotroski F-Score | 4 |